| Mental health interventions during the COVID-19 pandemic: a conceptual framework by early career psychiatrists R Ransing, F Adiukwu, V Pereira-Sanchez, R Ramalho, L Orsolini, ... Asian journal of psychiatry 51, 102085, 2020 | 232 | 2020 |
| Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: Drivers, facilitators, manifestations, and outcomes across the world R Ransing, R Ramalho, R de Filippis, MI Ojeahere, R Karaliuniene, ... Brain, behavior, and immunity 89, 555, 2020 | 211 | 2020 |
| COVID-19 effect on mental health: patients and workforce V Pereira-Sanchez, F Adiukwu, S El Hayek, DG Bytyçi, JM Gonzalez-Diaz, ... The Lancet Psychiatry 7 (6), e29-e30, 2020 | 193 | 2020 |
| Can COVID-19 related mental health issues be measured? R Ransing, R Ramalho, L Orsolini, F Adiukwu, JM Gonzalez-Diaz, ... Brain, behavior, and immunity 88, 32, 2020 | 143 | 2020 |
| Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial M Shalbafan, P Mohammadinejad, SV Shariat, K Alavi, A Zeinoddini, ... Pharmacopsychiatry 48 (04/05), 136-140, 2015 | 82 | 2015 |
| Telepsychiatry and healthcare access inequities during the COVID-19 pandemic R Ramalho, F Adiukwu, DG Bytyçi, S El Hayek, JM Gonzalez-Diaz, ... Asian Journal of Psychiatry 53, 102234, 2020 | 77 | 2020 |
| Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial M Ghazizadeh-Hashemi, A Ghajar, MR Shalbafan, ... Journal of affective disorders 232, 127-133, 2018 | 74 | 2018 |
| Minocycline combination therapy with fluvoxamine in moderate‐to‐severe obsessive–compulsive disorder: A placebo‐controlled, double‐blind, randomized trial S Esalatmanesh, Z Abrishami, A Zeinoddini, F Rahiminejad, M Sadeghi, ... Psychiatry and clinical neurosciences 70 (11), 517-526, 2016 | 73 | 2016 |
| Telepsychiatry during the COVID-19 pandemic: development of a protocol for telemental health care R Ramalho, F Adiukwu, D Gashi Bytyci, S El Hayek, JM Gonzalez-Diaz, ... Frontiers in psychiatry 11, 552450, 2020 | 63 | 2020 |
| The grief experience during the COVID-19 pandemic across different cultures F Adiukwu, L Kamalzadeh, M Pinto da Costa, R Ransing, R de Filippis, ... Annals of general psychiatry 21 (1), 18, 2022 | 59 | 2022 |
| Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial M Khalaj, A Saghazadeh, E Shirazi, MR Shalbafan, K Alavi, ... Journal of psychiatric research 103, 104-111, 2018 | 53 | 2018 |
| Scaling up global mental health services during the COVID-19 pandemic and beyond F Adiukwu, R de Filippis, L Orsolini, D Gashi Bytyçi, S Shoib, R Ransing, ... Psychiatric Services 73 (2), 231-234, 2022 | 52 | 2022 |
| L‐carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double‐blind study S Arabzadeh, M Shahhossenie, B Mesgarpour, F Rezaei, MR Shalbafan, ... Human Psychopharmacology: clinical and experimental 32 (4), e2584, 2017 | 48 | 2017 |
| Global perspective and ways to combat stigma associated with COVID-19 F Adiukwu, DG Bytyçi, SE Hayek, JM Gonzalez-Diaz, A Larnaout, ... Indian journal of psychological medicine 42 (6), 569-574, 2020 | 46 | 2020 |
| Stigma toward substance use disorders: A multinational perspective and call for action S El Hayek, W Foad, R De Filippis, A Ghosh, N Koukach, ... Frontiers in psychiatry 15, 1295818, 2024 | 45 | 2024 |
| Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled … S Askari, S Mokhtari, SV Shariat, B Shariati, M Yarahmadi, M Shalbafan BMC psychiatry 22 (1), 34, 2022 | 45 | 2022 |
| Cognitive rehabilitation for improving cognitive functions and reducing the severity of depressive symptoms in adult patients with Major Depressive Disorder: a systematic … S Mokhtari, A Mokhtari, F Bakizadeh, A Moradi, M Shalbafan BMC psychiatry 23 (1), 77, 2023 | 41 | 2023 |
| Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis F Hadi, S Kashefinejad, L Kamalzadeh, S Hoobehfekr, M Shalbafan BMC Pharmacology and Toxicology 22 (1), 69, 2021 | 40 | 2021 |
| L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial B Araminia, M Shalbafan, A Mortezaei, E Shirazi, S Ghaffari, ... Journal of Affective Disorders 267, 131-136, 2020 | 40 | 2020 |
| What COVID-19 outbreak in Iran teaches us about virtual medical education K Aghakhani, M Shalbafan Medical Education Online 25 (1), 1770567, 2020 | 40 | 2020 |
